First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency)

P. W. Speiser, N. Laforgia, K. Kato, J. Pareira, R. Khan, S. Y. Yang, C. Whorwood, P. C. White, S. Elias, E. Schriock, E. Schriock, J. L. Simpson, M. Taslimi, J. Najjar, S. May, G. Mills, C. Crawford, M. I. New

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)707-709
Number of pages3
JournalObstetrical and Gynecological Survey
Volume45
Issue number10
DOIs
StatePublished - Oct 1990

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Speiser, P. W., Laforgia, N., Kato, K., Pareira, J., Khan, R., Yang, S. Y., Whorwood, C., White, P. C., Elias, S., Schriock, E., Schriock, E., Simpson, J. L., Taslimi, M., Najjar, J., May, S., Mills, G., Crawford, C., & New, M. I. (1990). First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency). Obstetrical and Gynecological Survey, 45(10), 707-709. https://doi.org/10.1097/00006254-199010000-00020